QI-Core Implementation Guide: STU 3.2 (v3.2.0 for FHIR 3.0.1)

This page is part of the Quality Improvement Core Framework (v3.2.0: STU 3) based on FHIR R3. The current version which supercedes this version is 4.1.1. For a full list of available versions, see the Directory of published versions

D.4.1.4 StructureDefinition: qicore-allergyintolerance - Mappings

Mappings for the StructureDefinition-qicore-allergyintolerance Profile.

Mappings for Quality Data Model (http://www.healthit.gov/quality-data-model)

QICore-AllergyIntolerance
AllergyIntoleranceAllergy/Intolerance
   idid
   extension (resolutionAge)prevalencePeriod
   codecode
   assertedDateauthorDatetime
   recorderrecorder
   assertersource
   reaction
      manifestationtype
      onsetprevalencePeriod
      severityseverity

Mappings for Argonaut-DQ-DSTU2 (http://unknown.org/Argonaut-DQ-DSTU2)

QICore-AllergyIntolerance
AllergyIntoleranceAllergyIntolerance
   clinicalStatusAllergyIntolerance.status
   verificationStatusAllergyIntolerance.status
   codeAllergyIntolerance.substance
   patientAllergyIntolerance.patient

Mappings for RIM Mapping (http://hl7.org/v3)

QICore-AllergyIntolerance
AllergyIntoleranceEntity. Role, or Act
   textAct.text?
   containedN/A
   modifierExtensionN/A
   identifierid
   clinicalStatusObservation ACT .inboundRelationship[typeCode=COMP].source[classCode=OBS, code="clinicalStatus", moodCode=EVN].value
   verificationStatusObservation ACT .inboundRelationship[typeCode=COMP].source[classCode=OBS, code="verificationStatus", moodCode=EVN].value
   typecode
   categoryvalue < IntoleranceValue (Agent)
   criticalityinboundRelationship[typeCode=SUBJ].source[classCode=OBS, moodCode=EVN, code=SEV, value <= SeverityObservation (Severity Level)]
   codesubstance/product: .participation[typeCode=CAGNT].role[classCode=ADMM].player[classCode=MAT, determinerCode=KIND, code <= ExposureAgentEntityType] negated/excluded substance/product: .participation[typeCode=CAGNT, negationInd=true].role[classCode=ADMM].player[classCode=MAT, determinerCode=KIND, code <= ExposureAgentEntityType] positive or negated/excluded condition/situation: Observation.code=ASSERTION; Observation.value
   patient.participation[typeCode=SBJ].role[classCode=PAT]
   onset[x]effectiveTime.low
   assertedDate.participation[typeCode=AUT].time
   recorder.participation[typeCode=AUT].role
   asserter.participation[typeCode=INF].role
   lastOccurrenceoutBoundRelationship[typeCode=SUBJ].target[classCode=OBS, moodCode=EVN, code <= CommonClinicalObservationType, value <= ObservationValue (Reaction Type)].effectiveTime
   notesubjectOf.observationEvent[code="annotation"].value
   reactionoutBoundRelationship[typeCode=SUBJ].target[classCode=OBS, moodCode=EVN, code <= CommonClinicalObservationType, value <= ObservationValue (Reaction Type)]
      idn/a
      modifierExtensionN/A
      substanceoutBoundRelationship[typeCode=SAS].target[classCode=SBADM, code <= ExposureCode].participation[typeCode=CSM].role[classCode=ADMM].player[classCode=MAT, determinerCode=KIND, code <= ExposureAgentEntityType]
      manifestationcode
      descriptiontext
      onseteffectiveTime.low
      severityinboundRelationship[typeCode=SUBJ].source[classCode=OBS, moodCode=EVN, code=SEV, value <= SeverityObservation (Severity Level)]
      exposureRouteoutBoundRelationship[typeCode=SAS].target[classCode=SBADM, code <= ExposureCode].routeCode
      notesubjectOf.observationEvent[code="annotation"].value

Mappings for W5 Mapping (http://hl7.org/fhir/w5)

QICore-AllergyIntolerance
AllergyIntoleranceclinical.general
   identifierid
   clinicalStatusstatus
   verificationStatusstatus
   typeclass
   categoryclass
   criticalitygrade
   codewhat
   patientwho.focus
   onset[x]when.init
   assertedDatewhen.recorded
   recorderwho.author
   asserterwho.source

Mappings for HL7 v2 Mapping (http://hl7.org/v2)

QICore-AllergyIntolerance
AllergyIntolerance
   identifierIAM-7
   typeIAM-9
   categoryAL1-2
   criticalityAL1-4
   codeAL1-3 / IAM-3
   patient(PID-3)
   assertedDateIAM-20
   asserterIAM-14 (if patient) / IAM-18 (if practitioner)
   reaction
      manifestationAL1-5
      onsetAL1-6